Structural basis of the inhibition of GH1 β-glucosidases by multivalent pyrrolidine iminosugars.
Crystallography, X-Ray
Dose-Response Relationship, Drug
Enzyme Inhibitors
/ chemical synthesis
Imino Sugars
/ chemical synthesis
Models, Molecular
Molecular Structure
Paenibacillus polymyxa
/ enzymology
Pyrrolidines
/ chemical synthesis
Structure-Activity Relationship
beta-Glucosidase
/ antagonists & inhibitors
GH1 glycosidases
Iminosugars
Klotho proteins
Multivalency
Pyrrolidines
β-glucosidase inhibitors
Journal
Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
02
05
2019
revised:
24
05
2019
accepted:
30
05
2019
pubmed:
22
6
2019
medline:
23
9
2020
entrez:
22
6
2019
Statut:
ppublish
Résumé
The synthesis of multivalent pyrrolidine iminosugars via CuAAC click reaction between different pyrrolidine-azide derivatives and tri- or hexavalent alkynyl scaffolds is reported. The new multimeric compounds, together with the monomeric reference, were evaluated as inhibitors against two homologous GH1 β-glucosidases (BglA and BglB from Paenibacillus polymyxa). The multivalent inhibitors containing an aromatic moiety in the linker between the pyrrolidine and the scaffold inhibited the octameric BglA (µM range) but did not show affinity against the monomeric BglB, despite the similarity between the active site of both enzymes. A modest multivalent effect (rp/n = 12) was detected for the hexavalent inhibitor 12. Structural analysis of the complexes between the monomeric and the trimeric iminosugar inhibitors (4 and 10) and BglA showed the insertion of the inhibitors at the active site of BglA, confirming a competitive mode of inhibition as indicated by enzyme kinetics. Additionally, structural comparison of the BglA/4 complex with the reported BglB/2F-glucose complex illustrates the key determinants responsible for the inhibitory effect and explains the reasons of the inhibition of BglA and the no inhibition of BglB. Potential inhibition of other β-glucosidases with therapeutic relevance is discussed under the light of these observations.
Identifiants
pubmed: 31226649
pii: S0045-2068(19)30648-0
doi: 10.1016/j.bioorg.2019.103026
pii:
doi:
Substances chimiques
Enzyme Inhibitors
0
Imino Sugars
0
Pyrrolidines
0
beta-Glucosidase
EC 3.2.1.21
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
103026Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.